These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38427136)

  • 1. Vitiligo is associated with new-onset osteoporosis: a retrospective cohort study.
    Cohen NT; Silverberg NB; Kridin K
    Arch Dermatol Res; 2024 Mar; 316(3):94. PubMed ID: 38427136
    [No Abstract]   [Full Text] [Related]  

  • 2. Defining the psychological comorbidity in vitiligo: systematically casting the net wide.
    Thomson J
    Br J Dermatol; 2018 Apr; 178(4):826. PubMed ID: 29668098
    [No Abstract]   [Full Text] [Related]  

  • 3. Vitiligo and systemic sclerosis: Are they associated?- Lessons from a population-based study.
    Kridin K; Lyakhovitsky K; Tzur-Bitan D; Onn E; Lyakhovitsky A; Zoller L; Cohen AD
    Australas J Dermatol; 2023 Feb; 64(1):e65-e71. PubMed ID: 36326157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbid diagnosis of systemic lupus erythematosus in vitiligo: a systematic review and meta-analysis.
    Li HO; Bailey AMJ; Pastukhova E; Tan MG; Kirchhof MG
    Br J Dermatol; 2023 Feb; 188(3):440-441. PubMed ID: 36680305
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychological comorbidities of vitiligo: a retrospective cross-sectional analysis in an urban population.
    Montgomery SN; Syder N; Barajas G; Elbuluk N
    Arch Dermatol Res; 2023 Dec; 316(1):14. PubMed ID: 38047925
    [No Abstract]   [Full Text] [Related]  

  • 6. Demographic and clinical characteristics of patients with both psoriasis and vitiligo in a cohort of vitiligo patients: a cross-sectional study.
    Canu D; Shourick J; Andreu N; Gey A; Ballanger-Désolneux F; Barailler H; Boniface K; Ezzedine K; Seneschal J
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e676-e679. PubMed ID: 34013570
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of vitiligo and inflammatory arthropathy in hospitalized US adults.
    Patel KR; Justiz AM; Ahmed AM; Silverberg JI
    J Am Acad Dermatol; 2023 Dec; 89(6):1256-1257. PubMed ID: 37532138
    [No Abstract]   [Full Text] [Related]  

  • 8. The Incidence, Prevalence, and Mortality of Vitiligo in Korea: A Nationwide Population-Based Cohort Study.
    Lee YB; Kim S; Kim HS
    J Cutan Med Surg; 2023; 27(2):166-167. PubMed ID: 36579730
    [No Abstract]   [Full Text] [Related]  

  • 9. Commentary on vitiligo patient population and disease burden in France: VIOLIN Study results from the CONSTANCES cohort.
    Pandya AG
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2159-2160. PubMed ID: 37877764
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of association between vitiligo and major adverse cardiovascular events: A population-based cohort study.
    Wu PC; Ma SH; Wu CY; Pan TY; Chang YT; Wu CY
    J Eur Acad Dermatol Venereol; 2023 Jun; 37(6):e773-e775. PubMed ID: 36734285
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence of childhood-onset vitiligo and increased risk of atopic dermatitis, autoimmune diseases, and psoriasis: A nationwide population-based study.
    Lim JH; Lew BL; Sim WY; Kwon SH
    J Am Acad Dermatol; 2022 Nov; 87(5):1196-1198. PubMed ID: 35276286
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoimmune, inflammatory, allergic and neuropsychiatric outcomes of offspring born to mothers with vitiligo: a nationwide Korean population-based birth cohort study.
    Han JH; Ju HJ; Kang H; Lee JH; Lee S; Bae JM
    Br J Dermatol; 2023 Sep; 189(4):488-490. PubMed ID: 37335952
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiotherapy-induced vitiligo: A systematic review of patient demographics and clinical characteristics of vitiligo following radiation therapy.
    Mansour MR; Abushukur Y; Rehman RA; Shah C; Mehregan D
    J Am Acad Dermatol; 2022 Dec; 87(6):1445-1448. PubMed ID: 35995610
    [No Abstract]   [Full Text] [Related]  

  • 14. Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan.
    Chen YT; Chen YJ; Hwang CY; Lin MW; Chen TJ; Chen CC; Chu SY; Lee DD; Chang YT; Liu HN
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1362-9. PubMed ID: 25510261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pigment Loss in Patients with Large Congenital Melanocytic Nevi: Various Clinical Presentations Documented in a Large Series.
    Polat Ekinci A; Kiliç S; Baykal C
    Pediatr Dermatol; 2016 May; 33(3):307-10. PubMed ID: 26935480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk for neurodegenerative disorders in Korean patients with vitiligo: A nationwide retrospective cohort study.
    Kim TG; Shin J; Hwang S; Lee SH; Chang Kim H; Oh SH
    J Am Acad Dermatol; 2019 Aug; 81(2):621-623. PubMed ID: 30654072
    [No Abstract]   [Full Text] [Related]  

  • 17. Demographics of Vitiligo in the DataDerm Database.
    Cunningham KN; Alsukait S; Learned C; Deverapalli S; Aninos A; Rosmarin D
    J Cutan Med Surg; 2023; 27(5):529-530. PubMed ID: 37522738
    [No Abstract]   [Full Text] [Related]  

  • 18. Different vitiligo characteristics as predictors of increased risk of metabolic syndrome and insulin resistance: A case-control study.
    Ibrahim S; El-Tahlawi S; Mogawer RM; El Ansary M; Esmat S; El-Hawary M
    J Cosmet Dermatol; 2022 Dec; 21(12):7170-7177. PubMed ID: 36208004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of COVID-19 related complications in vitiligo patients: A database study.
    Raiker R; Pakhchanian H; Salingaros S; Helm M
    J Dtsch Dermatol Ges; 2022 Nov; 20(11):1505-1508. PubMed ID: 36210055
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidemiology of vitiligo, associated autoimmune diseases and audiological abnormalities: Ankara study of 80 patients in Turkey.
    Akay BN; Bozkir M; Anadolu Y; Gullu S
    J Eur Acad Dermatol Venereol; 2010 Oct; 24(10):1144-50. PubMed ID: 20202047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.